Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis
Prif Awduron: | Anthony, D, Sibson, N, Losey, P, Piani, D, Leppert, D |
---|---|
Fformat: | Conference item |
Cyhoeddwyd: |
2009
|
Eitemau Tebyg
-
The antineoplastic properties of FTY720: Evidence for the repurposing of fingolimod
gan: Patmanathan, S.N., et al.
Cyhoeddwyd: (2015) -
Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.
gan: Anthony, D, et al.
Cyhoeddwyd: (2014) -
The Immunosuppressant FTY720 (Fingolimod) enhances Glycosaminoglycan depletion in articular cartilage
gan: Stradner Martin H, et al.
Cyhoeddwyd: (2011-12-01) -
Ameliorative effects of Fingolimod (FTY720) on microglial activation and psychosis-related behavior in short term cuprizone exposed mice
gan: Siyao Li, et al.
Cyhoeddwyd: (2023-07-01) -
The Immunosuppressant Fingolimod (FTY720) for the Treatment of Mechanical Force-Induced Abnormal Scars
gan: Masayo Aoki, et al.
Cyhoeddwyd: (2020-01-01)